Engene Therapeutics (ENGN)'s 30-day implied volatility (IV30) was 81.2% at the close on November 2, 2026, up from 75.7% the day before, against a 52-week range of 50.2% to 142.5%. Its 20-day historical volatility was 68.5%.
Data as of November 2, 2026.